de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons80410

Krumbholz,  M.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80321

Faber,  H.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80578

Weber,  F.
AG Weber, Frank, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80414

Kümpfel,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Havla, J., Gerdes, L. A., Meinl, I., Krumbholz, M., Faber, H., Weber, F., et al. (2011). De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. Journal of Neurology, 258(9), 1665-1669.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-8DBA-9
Abstract
There is no abstract available